331 related articles for article (PubMed ID: 10442211)
1. Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat.
Ueki S; Matsunaga Y; Yoneta T; Tamaki H; Itoh Z
Arzneimittelforschung; 1999 Jul; 49(7):618-25. PubMed ID: 10442211
[TBL] [Abstract][Full Text] [Related]
2. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
[TBL] [Abstract][Full Text] [Related]
3. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
[TBL] [Abstract][Full Text] [Related]
4. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
[TBL] [Abstract][Full Text] [Related]
5. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
J Pharmacol Exp Ther; 1998 Nov; 287(2):712-9. PubMed ID: 9808701
[TBL] [Abstract][Full Text] [Related]
6. Nizatidine accelerates gastric emptying of a solid meal in rats.
Kaneko H; Mitsuma T; Uchida K; Nagai H; Harada M; Kotera H
Dig Dis Sci; 1995 Sep; 40(9):2043-51. PubMed ID: 7555463
[TBL] [Abstract][Full Text] [Related]
7. Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.
Keto Y; Hirata T; Takemoto Y; Yamano M; Yokoyama T
Neurogastroenterol Motil; 2012 Feb; 24(2):147-53, e88. PubMed ID: 22066725
[TBL] [Abstract][Full Text] [Related]
8. [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
Dallera F; Scanzi G; Gendarini A
Clin Ter; 1994 Jan; 144(1):23-6. PubMed ID: 8168347
[TBL] [Abstract][Full Text] [Related]
9. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
[TBL] [Abstract][Full Text] [Related]
10. Clinical study on the effects of nizatidine on gastric motility and cardiac autonomic function. Investigations using electrogastrography and spectral analysis of heart rate variability.
Tomokane Y; Nomura M; Kujime S; Noda Y; Kondo N; Nakaya Y; Ito S
Arzneimittelforschung; 2004; 54(8):427-35. PubMed ID: 15460209
[TBL] [Abstract][Full Text] [Related]
11. Nizatidine and cisapride increase salivary secretion in rats.
Adachi K; Furuta K; Katsube T; Fujisawa T; Azumi T; Fujishiro H; Ishihara S; Amano Y; Kinoshita Y
Dig Dis Sci; 2004 Mar; 49(3):399-403. PubMed ID: 15139487
[TBL] [Abstract][Full Text] [Related]
12. Effect of novel motilide ABT-229 versus erythromycin and cisapride on gastric emptying in dogs.
Cowles VE; Nellans HN; Seifert TR; Besecke LM; Segreti JA; Mohning KM; Faghih R; Verlinden MH; Wegner CD
J Pharmacol Exp Ther; 2000 Jun; 293(3):1106-11. PubMed ID: 10869416
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W
Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835
[TBL] [Abstract][Full Text] [Related]
14. Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.
Lin TM; Evans DC; Warrick MW; Ruffolo RR
J Pharmacol Exp Ther; 1986 Nov; 239(2):400-5. PubMed ID: 3095539
[TBL] [Abstract][Full Text] [Related]
15. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of DQ-2511, a novel gastroprokinetic agent, with cisapride in ameliorative action on experimentally induced delayed gastric emptying.
Hatanaka S; Kawarabayashi K; Iseri M; Tsubokura K; Furuhama K; Nijima A
Neurogastroenterol Motil; 1996 Sep; 8(3):227-33. PubMed ID: 8878082
[TBL] [Abstract][Full Text] [Related]
17. Effect of cisapride on gastric motility.
Schuurkes J
Z Gastroenterol; 1990 Apr; 28 Suppl 1():27-30; discussion 44. PubMed ID: 2356634
[TBL] [Abstract][Full Text] [Related]
18. [The effect of prokinetic treatment and eradication of Helicobacter pylori on gastric emptying and symptoms of functional dyspepsia].
Radwan P; Grodzieński R; Zaorska-Rajca J; Skrzydło-Radomańska B; Słomka M; Wysokiński A
Wiad Lek; 2001; 54(1-2):38-44. PubMed ID: 11344699
[TBL] [Abstract][Full Text] [Related]
19. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
[TBL] [Abstract][Full Text] [Related]
20. Nizatidine and cisapride enhance salivary secretion in humans.
Adachi K; Ono M; Kawamura A; Yuki M; Fujishiro H; Kinoshita Y
Aliment Pharmacol Ther; 2002 Feb; 16(2):297-301. PubMed ID: 11860413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
